Everyone see this?
http://www.bizjournals.com/triangle/...2/daily71.html
"Clinical studies in Japan found that Diquas eased dry-eye symptoms by promoting the secretion of mucin and water. The drug also was found to be well tolerated in patients.
The drug that passed muster in Japan is different from Prolacria in two major ways, said Inspire spokeswoman Cara Amoroso. No. 1, Prolacria was a 2 percent diquafosol solution; Diquas is 3 percent. No. 2: Patients in the last Prolacria trial received four doses a day; patients in the Japanese tests used the eye drops six times a day"
http://www.bizjournals.com/triangle/...2/daily71.html
"Clinical studies in Japan found that Diquas eased dry-eye symptoms by promoting the secretion of mucin and water. The drug also was found to be well tolerated in patients.
The drug that passed muster in Japan is different from Prolacria in two major ways, said Inspire spokeswoman Cara Amoroso. No. 1, Prolacria was a 2 percent diquafosol solution; Diquas is 3 percent. No. 2: Patients in the last Prolacria trial received four doses a day; patients in the Japanese tests used the eye drops six times a day"
Comment